Artículos del autor

solaci

Peripheral vascular disease

EuroPCR 2023 | New Renal Denervation Devices Show Promising Results

The Netrod System study included 205 patients with uncontrolled essential hypertension while taking two drugs (nifedipine and hydrochlorothiazide),...
solaci -
Peripheral Vascular Disease

EuroPCR 2023 | More Evidence in Favor of Renal Denervation

This study included 219 patients with uncontrolled essential hypertension who had received at least two antihypertensive drugs. All...
solaci -
Chronic Coronary Syndromes

EuroPCR 2023 | Provisional Stenting is Still the First Choice

The EBC TWO in Non-LM study randomized 200 patients with bifurcation lesions not affecting the left main coronary...
solaci -
Coronary disease

EuroPCR 2023 | Left Main Coronary Artery Angioplasty: One or Two Stents?

The EBC MAIN LM study randomized 467 patients with severe left main coronary artery (LCA) lesions to receive...
solaci -
Structural Heart Disease

EuroPCR 2023 |Chimney Stenting vs BASILICA for the Prevention of Coronary Obstruction during TAVR

Coronary obstruction is a complication from TAVR that can cause death (up to 50% mortality), even though...
solaci -
Structural heart disease

EuroPCR 2023 |TAVR in Cardiogenic Shock

Patients presenting aortic stenosis with cardiogenic shock are at extreme risk, with 70% mortality until the aortic...
solaci -
Structural heart disease

EuroPCR 2023 | Events after Redo TAVR in Balloon-Expandable Valves

With the treatment of aortic valve disease in younger patients, a significant number of them will need...
solaci -
Bifurcations

EuroPCR 2023 | iFR vs FFR Guided Revascularization in Left Main De Novo Lesions

Acute coronary syndrome guidelines recommend the use of iFR and FFR guided invasive management for patients with...
solaci -